Kepler Vision Technologies Reports New Partnership

Kepler Vision Technologies continues to extend its reach across Europe by partnering with Norwegian company OneCo Technology. OneCo Technology, is a leader in cutting-edge technology solutions, and Kepler Vision, a renowned healthcare service provider with a deep understanding of local requirements, have joined forces to create a synergy that promises to revolutionise the way healthcare is delivered and managed in Norway.

The care industry is facing increasingly difficult challenges due to an aging population and workforce. While the population of 65+ continues to grow, the workforce sustaining care for this demographic is shrinking. At the core of this collaboration is the integration of advanced technologies into the existing healthcare infrastructure. Kepler Vision’s state-of-the-art innovations in artificial intelligence and digital healthcare solutions are seamlessly merging with OneCo Technology’s extensive experience in patient care, clinical workflows, and operational efficiency.

With the rise of AI, there has been a rapid acceptance of its benefits and use – albeit with some trepidation. With AI still in its infancy stage, there is much more room for growth. Both companies boast a wealth of experience and a passion for pushing boundaries that will lead to the development of innovative solutions that will undoubtedly set new benchmarks within the industry.

Utilising AI and computer vision learnings, Kepler Vision’s Night Nurse solution brings an exceptionally reliable fall detector. Pair this with OneCo’s expertise in patient care and there is potential for significantly improved patient outcomes and experiences.

This is the latest partnership that joins Kepler’s ever expanding network. It’s smart sensor technology is currently embedded in the Mobotix C71 camera but can be run with on any camera using on-premise servers. The product is being used in 8 European countries and is supported by Alcatel Lucent, KPN Health, Ascom, and others. Most recently, the health-tech company partnered with Yourizon, which added Kepler’s technology into its own product line.

Lene Høysæter Larsen, Head of Health Technology and Corporate Communications says: “This partnership between OneCo and Kepler is not just a collaboration; it’s a declaration of intent—a commitment to shaping the future of technology and data analytics. This alliance brings together the best of both worlds, fusing technological innovation with data-driven insights to empower businesses and drive unparalleled success.”

Harro Stokman, CEO of Kepler Vision Technologies says: “Working with companies like OneCo Technology provide so many benefits to not just eachother’s companies but also the patients and care workers using our products. As we continue to meet and collaborate with more innovative companies like OneCo across Europe, we can expect even better solutions to be developed.”

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”
Exit mobile version